BB
QTTB icon

BB Biotech’s Q32 Bio QTTB Stock Holding History

BB Biotech’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$2.53M Buy
+5,074
New +$2.27M 0.06% 35

Other funds holding QTTB

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VM
VV Manager Boston, Massachusetts $114M AUM 59.16% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BB Biotech's QTTB Position: Q1 2019 in Review

BB Biotech opened a new position in Q32 Bio (QTTB) in Q1 2019: 5,074 shares worth $2.53M. The stake represents 0.06% of the portfolio and ranks #35 among its holdings.

66 funds tracked by Wall St. Rank hold QTTB as of Q1 2019.

  • BB Biotech held 5,074 shares of Q32 Bio worth $2.53M as of Q1 2019.
  • Q32 Bio was a new BB Biotech position in Q1 2019.
  • Q32 Bio made up 0.06% of BB Biotech's portfolio in Q1 2019, its #35 holding.
  • 66 funds tracked by Wall St. Rank held Q32 Bio as of Q1 2019.

Based on BB Biotech's 13F filing for Q1 2019, filed 13 May 2019.